ABSTRACT
Background Returning university students represent large-scale, transient demographic shifts and a potential source of transmission to adjacent communities during the COVID-19 pandemic.
Methods In this prospective longitudinal cohort study, we tested for IgG antibodies against SARS-CoV-2 in a non-random cohort of residents living in Centre County prior to the Fall 2020 term at the Pennsylvania State University and following the conclusion of the Fall 2020 term. We also report the seroprevalence in a non-random cohort of students collected at the end of the Fall 2020 term.
Findings Of 345 community participants, 19 (5·5%) were positive for SARS-CoV-2 IgG antibodies at their first visit between 7 August and 2 October. Of 625 student participants who returned to campus for fall instruction, 195 (31·2%) were positive for SARS-CoV-2 antibodies between 26 October and 23 November. Twenty-eight (8·1%) community participants returned a positive IgG antibody result by 9 December. Only contact with known SARS-CoV-2-positive individuals and attendance at small gatherings (20-50 individuals) were significant predictors of detecting IgG antibodies among returning students (aOR, 95% CI: 3·24, 2·14-4·91; 1·62, 1·08-2·44; respectively).
Interpretation Despite high seroprevalence observed within the student population, seroprevalence in a longitudinal cohort of community residents was low and stable from before student arrival for the Fall 2020 term to after student departure. The study implies that heterogeneity in SARS-CoV-2 transmission can occur in geographically coincident populations.
Funding The Pennsylvania State University Office of the Provost, Social Science Research Institute, Huck Institute for the Life Sciences, and Clinical and Translational Science Institute; National Institutes of Health.
Evidence before this study This study was initiated in Spring of 2020, during the pandemic but prior to the return of students to US universities. There was no prior research on the consequences of the return to in-person university instruction on SARS-CoV-2 transmission. While the explicit case of transmission of SARS-CoV-2 between student and resident communities was poorly understood at the start of this study, there is a well-established literature that has documented the role that large population movements, consistent with the return of students to campuses, play in the introduction and maintenance of pathogen transmission or diseases. Several studies documented the role of travelers in the introduction of SARS-CoV-2 to populations. The return of students to colleges and universities creates the potential for SARS-CoV-2 introduction and transmission with a sustained increase in population size, density, and mixing. No prior study has considered the long-term transmission consequences of such demographic change on the pre-influx population. We searched PubMed, medRxiv, bioRxiv, and Google Scholar between May 2020 and September 2020. We used search terms “seroprevalence”, “anti-SARS-CoV-2”, “IgG”, “COVID antibodies” and “university”, “college”. Several modeling studies had been conducted to project likely prevalence of anti-SARS-CoV-2 antibodies in student and resident populations resulting from the return of students to in-person instruction in the Fall 2020 term in the US and UK. Several studies conducted after September 2020 described the county-level incidence of SARS-CoV-2 in counties that contain colleges and universities. None of these studies specifically disaggregated the incidence of COVID in resident and student populations.
Added value of this study There is clear evidence that in-person university instruction is correlated with high incidence in students and higher incidence in counties with colleges and universities in counties those without such institutions. However, this is the first study to specifically quantify the change in seroprevalence in non-student residents associated with the return of students to in-person instruction in a large university setting. Despite high COVID-19 incidence in the student population, seroprevalence in the community resident cohort was low and stable from before student arrival for the Fall 2020 term until after student departure. The results of this study highlight the potential for significant heterogeneity in incidence in geographically coincident sub-populations.
Implications of all the available evidence The influx of students into college and university towns reflects a significant increase in population size and density that could result in increases in COVID-19 risk in surrounding communities. Despite the potential risk, it is possible that SARS-CoV-2 transmission may lag behind in surrounding communities This implies the potential to minimize the transmission of SARS-CoV-2 from high prevalence sub-populations with targeted interventions. Future work should investigate the relative efficacy of specific measures to reduce risk of transmission between subpopulations and guide communities with high levels of episodic migration and similar high-density subpopulations.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://www.protocols.io/view/quantitative-estimation-of-igm-and-igg-antibodies-bivgke3w
Funding Statement
This research was supported by funding from the Office of the Provost and the Clinical and Translational Science Institute, Huck Life Sciences Institute, and Social Science Research Institutes at the Pennsylvania State University. The project described was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1 TR002014. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funding sources had no role in the collection, analysis, interpretation, or writing of the report.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This human subjects research was conducted with PSU Institutional Review Board approval (study number: STUDY00015547) and in accordance with the Declaration of Helsinki.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
At present, data is deemed to contain personal health information (PHI) so cannot be shared as per the IRB approval. However, at a later date, a clean dataset without PHI will be added to a public GitHub repository, and the submission information will be updated to include the appropriate links to the data and analysis files.
